Impact of bleeding on mortality after percutaneous coronary intervention: Results from a patient-level pooled analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events), ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy), and HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trials

JACC: Cardiovascular Interventions

Volumn 4, Issue 6, 2011, Pages 654-664

  Mehran, Roxana ^a,i   Pocock, Stuart ^f   Nikolsky, Eugenia ^a   Dangas, George D ^a   Clayton, Tim ^f   Claessen, Bimmer E ^a   Caixeta, Adriano ^a   Feit, Frederick ^b   Manoukian, Steven V ^c   White, Harvey ^g   Bertrand, Michel ^h   Ohman, E Magnus ^d   Parise, Helen ^a   Lansky, Alexandra J ^a   Lincoff, A Michael ^e   Stone, Gregg W ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL CORPORATION OF AMERICA   (United States)

^d DUKE UNIVERSITY   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

bleeding; mortality; myocardial infarction; risk score

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATININE; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEMOGLOBIN; HEPARIN; HIRULOG; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CARDIAC PATIENT; CIGARETTE SMOKING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE DURATION; EMERGENCY HEALTH SERVICE; ERYTHROCYTE TRANSFUSION; FEMALE; HEART CATHETERIZATION; HEMATOMA; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRAOCULAR HEMORRHAGE; ISCHEMIA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROPERITONEAL HEMORRHAGE; REVASCULARIZATION; RISK ASSESSMENT; SEX DIFFERENCE; TREATMENT DURATION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTITHROMBINS; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HEALTH STATUS INDICATORS; HEMORRHAGE; HEPARIN; HIRUDINS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PEPTIDE FRAGMENTS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECOMBINANT PROTEINS; RISK ASSESSMENT; RISK FACTORS; TRIAGE;

EID: 79959508168     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.02.011     Document Type: Article

References (31)

1. S.V. Rao, J.A. Eikelboom, C.B. Granger, R.A. Harrington, R.M. Califf, and J.P. Bassand Bleeding and blood transfusion issues in patients with nonST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1193 1204 (Pubitemid 47343833)
2. S.K. Mehta, A.D. Frutkin, J.B. Lindsey National Cardiovascular Data Registry Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry Circ Cardiovasc Interv 2 2009 222 229
3. B.J. Doyle, C.S. Rihal, D.A. Gastineau, and D.R. Holmes Jr Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice J Am Coll Cardiol 53 2009 2019 2027
4. T.D. Kinnaird, E. Stabile, and G.S. Mintz Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions Am J Cardiol 92 2003 930 935 (Pubitemid 37214804)
5. S.V. Rao, K. O'Grady, and K.S. Pieper Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206 (Pubitemid 41505393)
6. M. Moscucci, K.A. Fox, and C.P. Cannon Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823 (Pubitemid 37280247)
7. S.V. Rao, K. O'Grady, and K.S. Pieper A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes J Am Coll Cardiol 47 2006 809 816 (Pubitemid 43243106)
8. J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782 (Pubitemid 44268228)
9. A.J. Kirtane, G. Piazza, S.A. Murphy TIMI Study Group Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial J Am Coll Cardiol 47 2006 2374 2379 (Pubitemid 43866383)
10. S.V. Manoukian, F. Feit, and R. Mehran Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial J Am Coll Cardiol 49 2007 1362 1368 (Pubitemid 46476844)
11. F. Feit, M.D. Voeltz, and M.J. Attubato Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial Am J Cardiol 100 2007 1364 1369 (Pubitemid 47576015)
12. R. Mehran, S.J. Pocock, and G.W. Stone Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial Eur Heart J 30 2009 1457 1466
13. R. Mehran, S.J. Pocock, and E. Nikolsky A risk score to predict bleeding in patients with acute coronary syndromes J Am Coll Cardiol 55 2010 2556 2566
14. H.D. White, P.E. Aylward, R. Gallo STEEPLE Investigators Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an international randomized Evaluation (STEEPLE) trial Am Heart J 159 2010 110 116
15. G.W. Stone, M. Bertrand, and A. Colombo Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial: study design and rationale Am Heart J 148 2004 764 775
16. G.W. Stone, B. Witzenbichler, G. Guagliumi HORIZONS-AMI Trial Investigators Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230 (Pubitemid 351724451)
17. A.M. Lincoff, N.S. Kleiman, D.J. Kereiakes REPLACE-2 Investigators Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial JAMA 292 2004 696 703 (Pubitemid 39062523)
18. G.W. Stone, J.H. Ware, M.E. Bertrand ACUITY Investigators Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial JAMA 298 2007 2497 2506 (Pubitemid 350223536)
19. R. Mehran, B. Brodie, and D.A. Cox The Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial: study design and rationale Am Heart J 156 2008 44 56 (Pubitemid 351862292)
20. A.K. Rao, C. Pratt, and A. Berke Thrombolysis in Myocardial Infarction (TIMI) trialphase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11 (Pubitemid 18029027)
21. D.G. Altman, and B.L. De Stavola Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates Stat Med 13 1994 301 341 (Pubitemid 24048573)
22. S.J. Pocock, R. Mehran, and T.C. Clayton Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation 121 2010 43 51
23. H.D. Aronow, P.A. Peyser, and K.A. Eagle Predictors of length of stay after coronary stenting Am Heart J 142 2001 799 805 (Pubitemid 33016196)
24. A. Segev, B.H. Strauss, M. Tan, C. Constance, A. Langer, and S.G.the Canadian Acute Coronary Syndromes Registries Investigators. Goodman Predictors and 1-year outcome of major bleeding in patients with nonST-elevation acute coronary syndromes: insights from the Canadian Acute Coronary Syndrome Registries Am Heart J 150 2005 690 694 (Pubitemid 41396500)
25. F.A. Spencer, M. Moscucci, C.B. Granger GRACE Investigators Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 116 2007 2793 2801 (Pubitemid 350291221)
26. T.Y. Wang, L. Xiao, and K.P. Alexander Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding Circulation 118 2008 2139 2145
27. S.V. Rao, J.G. Jollis, and R.A. Harrington The relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JAMA 292 2004 1555 1562 (Pubitemid 39314961)
28. S. Subherwal, R.G. Bach, and A.Y. Chen Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) bleeding score Circulation 119 2009 1873 1882
29. A.P. Amin, S.P. Marso, and S.V. Rao Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding Circ Cardiovasc Qual Outcomes 3 2010 358 365
30. S.V. Rao, F.S. Ou, and T.Y. Wang Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry J Am Coll Cardiol Intv 1 2008 379 386
31. A. Vorobcsuk, A. Kónyi, and D. Aradi Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction: systematic overview and meta-analysis Am Heart J 158 2009 814 821